Axsome Therapeutics Inc (AXSM) support and resistance · rev $409.6M
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
This page maps Axsome Therapeutics Inc (AXSM) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
AXSM currently screens at market cap $11.96B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new AXSM 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the AXSM quote page for the session range and the stock page for the full model.
Not investment advice.